Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder

Eker S. S., Akkaya C., Akgoz S., Sarandol A., Kirli S.

TURK PSIKIYATRI DERGISI, vol.16, no.3, pp.153-163, 2005 (SSCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 3
  • Publication Date: 2005
  • Journal Name: TURK PSIKIYATRI DERGISI
  • Journal Indexes: Social Sciences Citation Index (SSCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.153-163
  • Keywords: depression, reboxetine, sertraline, SEROTONIN REUPTAKE INHIBITORS, DOUBLE-BLIND, RATING-SCALE, ANTIDEPRESSANT, FLUOXETINE, PLACEBO, NOREPINEPHRINE, NORADRENALINE, ANXIETY, TOLERABILITY
  • Bursa Uludag University Affiliated: Yes

Abstract

Objective: To compare the efficacy, safety and tolerability of reboxetine and sertraline in major depressive disorder (MDD).